Therefore, the effect of hypercortisolism on FGF23 and urinary phosphate excretion should be further evaluated in a prospective setting and all patients with CS should be evaluated for hypophosphatemia, especially when it concerns CS from ectopic ACTH production. The gene discussed is POMC; the disease is hypophosphatemia.